EV/EBITDA
-10.67
+0.03+0.28%
Fri, 03 Jan 2025 21:03:07 GMT
Summary:
NewAmsterdam Pharma Company NV Ordinary Shares EV/EBITDA is currently -10.67, with a rise of +0.03 (+0.28%) during the most recent trading day. Over the past year, it has dropped by -6.97 (-188.38%). NAMS EV/EBITDA is now -225.30% below its all-time high of -3.28.NAMS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NAMS EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +0.3% |
| 1 m1 month | -38.2% |
| 3 m3 months | -61.2% |
| 6 m6 months | -63.4% |
| ytdytd | +1.2% |
| 1 y1 year | -188.4% |
| 5 y5 years | - |
NAMS EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -6.90 | -54.6% | -11.65 | +8.4% |
| 3 m | 3 months | -6.53 | -63.4% | -11.65 | +8.4% |
| 6 m | 6 months | -4.68 | -128.0% | -11.65 | +8.4% |
| 1 y | 1 year | -3.68 | -189.9% | -11.65 | +8.4% |
| 3 y | 3 years | -3.28 | -225.3% | -11.65 | +8.4% |
| 5 y | 5 years | -3.28 | -225.3% | -11.65 | +8.4% |
| alltime | all time | -3.28 | -225.3% | -11.65 | +8.4% |
NewAmsterdam Pharma Company NV Ordinary Shares EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -10.67(-1.2%) |
| Date | Value |
|---|---|
| 2024 | -10.80(+229.3%) |
| 2023 | -3.28 |
FAQ
- What is NewAmsterdam Pharma Company NV Ordinary Shares EV/EBITDA?
- What is the all time high EV/EBITDA for NewAmsterdam Pharma Company NV Ordinary Shares?
- What is NAMS EV/EBITDA year-to-date change?
- What is NewAmsterdam Pharma Company NV Ordinary Shares EV/EBITDA year-on-year change?
What is NewAmsterdam Pharma Company NV Ordinary Shares EV/EBITDA?
The current EV/EBITDA of NAMS is -10.67
What is the all time high EV/EBITDA for NewAmsterdam Pharma Company NV Ordinary Shares?
NewAmsterdam Pharma Company NV Ordinary Shares all-time high EV/EBITDA is -3.28
What is NAMS EV/EBITDA year-to-date change?
NewAmsterdam Pharma Company NV Ordinary Shares EV/EBITDA has changed by +0.13 (+1.20%) since the beginning of the year
What is NewAmsterdam Pharma Company NV Ordinary Shares EV/EBITDA year-on-year change?
Over the past year, NAMS EV/EBITDA has changed by -6.97 (-188.38%)